| September 2018 |
A little B12 Helps the Medicine Go Down
A study reported July 2018 by researchers at the University of Pennsylvania and Syracuse University highlights a discovery they hope will improve medication therapy for individuals diagnosed with type 2 diabetes through the modification of currently available drug therapy with a resulting alternative agent that has fewer side effects and may increase adherence. Read more. |
|
|
Popular Ketogenic Diet May Contribute to Diabetes
A study published July 2018 in the Journal of Physiology highlights work done by a team led by researchers affiliated with Institute of Food Nutrition and Health at the ETH Zurich evaluating the potential role that a ketogenic diet plays in increasing the risk of type 2 diabetes and what the short-term ketogenic diet does to hepatic insulin resistance. Read more.
|
|
|
SGLT2 Inhibitor Tool Seeks to Help Prescribers
A reference tool published July 2018 in Diabetes Therapy highlights a new way for prescribers to guide the incorporation of sodium-glucose cotransporter-2 inhibitors—associated with potential misconceptions surrounding their efficacy and safety—in the overall medication management of type 2 diabetes. Read more. |
|
|
Connect With U.S. Pharmacist
    |
